Eimskip: Transaction in relation to a share buy-back program

In week 45 2023 Eimskip purchased 165,000 of its own shares, at a purchase price of ISK 74,217,000 as further stipulated below:

Date	Time	No. of shares	Share price	Purchase price
6.11.2023	10:11	33,000	450.00	14,850,000
7.11.2023	09:44	33,000	449.00	14,817,500
8.11.2023	10:15	33,000	450.00	14,850,000
9.11.2023	14:17	33,000	450.50	14,866,500
10.11.2023	10:07	33,000	449.50	14,833,500
Total		165,000		74,217,000

The trade is in accordance with Eimskip‘s buy-back program as published on Nasdaq Iceland on 10 October 2023.

Eimskip held 2,319,320  own shares prior to the notified transactions, and holds 2,484,320 after them, or the equivalent of 1.48% of issued shares in the company.

Under current buy-back program Eimskip has purchased a total of 759,000 shares in the company, corresponding to 35.30% of the maximum amount of shares to be purchased under this program. Total purchase price is ISK 355,014,000 corresponding to 35,50% of the maximum ISK amount of the buy-back program.

Buy-back under the program will amount to a maximum of 2,150,000 shares and the market value amount will not exceed ISK 1,000,000,000. The buy-back program is in effect for 18 months post the Annual General Meeting held 9 March 2023, unless the conditions for maximum purchase are met before that time.

The execution of the buy-back program is according to Act on Public Limited Companies, No. 2/1995. In addition, the buy-back program must be implemented as provided for in the Regulation of the European Parliament and of the Council no. 596/2014, on market abuse, as well as the Commission Delegated Regulation (EU) 2016/1052 on regulatory technical standards for the conditions applicable to buy-back programs and stabilization measures, which supplements that Regulation.

For further information please contact
Guðbjörg Birna Björnsdóttir, Head of Treasury and Investor Relations, tel: +354 844 4752, email:  investors@eimskip.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.